In a groundbreaking medical achievement that marks a world first, scientists have successfully used a woman’s own stem cells to restore her Type 1 diabetes, offering renewed hope for the millions of people worldwide living with this autoimmune condition. By taking cells from her own body, reprogramming them into insulin-producing islet cells, and transplant Ced back into her abdomen, researchers were able to restore insulin-producing beta cells in her pancreas—effectively reversing the disease. Within months, she was able to produce insulin without the need for continual insulin injections or external pumps.

This innovative therapy represents a major shift in how Type 1 diabetes may be treated in the future. For decades, the standard of care has been lifelong insulin therapy, but this new approach could one day offer a functional cure.

Researchers used induced pluripotent stem cells (iPSCs)—adult cells that are reprogrammed in the laboratory to behave like embryonic stem cells. These iPSCs were then coaxed into becoming functional pancreatic islet cells capable of sensing blood glucose levels and releasing insulin accordingly, just like healthy beta cells do.

The patient, a 25-year-old woman, received the transplant in 2024. Within 75 days, she began producing her own insulin, and by one year after the procedure, she no longer required any exogenous insulin while maintaining stable blood glucose levels.

Although the procedure is still in early stages of research and requires further trials to confirm safety, scalability, and long-term effectiveness, the implications are extraordinary. This breakthrough demonstrates that Type 1 diabetes can potentially be reversed using a patient’s own reprogrammed cells—eliminating the need for daily insulin injections, reducing complications, and offering hope that one day this devastating disease could be functionally cured rather than just managed.

Most importantly, it stands as a powerful reminder that medical science continues to redefine what is possible. Breakthroughs like this don’t happen overnight—they are the result of decades of research and translation scientists who refused to accept that lifelong insulin dependence was the only option for people with Type 1 diabetes. While we’re not there yet for widespread clinical application, for the first time in history, a human being with Type 1 diabetes has potentially been cured using her own cells.